| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9404821 | Surgery | 2005 | 7 Pages |
Abstract
Survivin may play an important role as 1 of the radioresistance factors. Downregulation of survivin by siRNA can diminish the radioresistance of pancreatic cancer cells, so combined therapy with survivin inhibition and radiation may be useful for the treatment of pancreatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kazuhiro MD, Ryuichiro MD, Masayuki MD, Eiji MD, Tomohiko MD, Daisuke MD, Yoshiya MD, Koji MD, Michihiko MD, Shin-Ichi MD, Masayuki MD,